Brief: Zevra Therapeutics Q1 Operating Expenses USD 22.803 Million
13/05/2025 21:29
May 13 (Reuters) - Zevra Therapeutics Inc ZVRA.O: ZEVRA THERAPEUTICS Q1 OPERATING EXPENSES USD 22.803 MILLION ZEVRA THERAPEUTICS Q1 REVENUE USD 20.401 MILLION VERSUS. IBES ESTIMATE USD 17 MILLION ZEVRA THERAPEUTICS Q1 INCOME FROM OPERATIONS USD -5.362 MILLION VERSUS. IBES ESTIMATE USD -9.44 MILLION ZEVRA THERAPEUTICS Q1 PRETAX PROFIT USD -1.917 MILLION VERSUS. IBES ESTIMATE USD -10.4 MILLION ZEVRA THERAPEUTICS Q1 NET INCOME USD -3.099 MILLION VERSUS. IBES ESTIMATE USD -10.4 MILLION Source text: ID:nGNXGHxVs Further company coverage: ZVRA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zevra Therapeutics
See all newsZevra Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Zevra Therapeutics Q2 revenue rises 53% on MIPLYFFA sales
Zevra Therapeutics Inc expected to post earnings of 11 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tenet, SLB, Digital Realty
U.S. STOCKS ON THE MOVE-Booz Allen Hamilton, Sensient, Amkor